Prospective Assessment of the Rockall Risk ScoringSystem in Patients With Upper Gastrointestinal Hemorrhage
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02405286|
Recruitment Status : Completed
First Posted : April 1, 2015
Last Update Posted : April 1, 2015
|Condition or disease||Intervention/treatment|
|Gastrointestinal Bleeding||Other: Upper gastrointestinal endoscopy|
This present study aimed to evaluate:
Assess the validity of the Rockall score for the prediction of rebleeding and death in patients with upper gastrointestinal bleeding.
1- Technical Design: The technical design included research design, setting, subject and tools for data collection.
A descriptive exploratory design was followed to achieve the aim of the study. Study setting: This study was conducted between Tropical department in AinShams university and Gastroenterology and Hepatology department in TheodorBilharz Research Institute.
Sample size: EPI - INFO program version 6 was used for sample size calculation guided by power of the test = 80% - confidence level =95% and accepted margin of error = 5% and risk ratio = 5.5 - total sample minimum accepted = 50 This study included 50 recipients and done Tropical department in Ain Shams university and Gastroenterology and Hepatology department in .
Theodore Bilharz Research Institute
|Study Type :||Observational|
|Actual Enrollment :||50 participants|
|Official Title:||Prospective Assessment of the Rockall Risk ScoringSystem in Patients With Upper Gastrointestinal Hemorrhage|
|Study Start Date :||May 2014|
|Actual Primary Completion Date :||December 2014|
|Actual Study Completion Date :||December 2014|
Upeer gastrointestinal bleeding
Other: Upper gastrointestinal endoscopy
Upper gastrointestinal endoscopy, if stigmata of recent hemorrhage are seen, varices are either injected with ethanolamine or banded, depending on the clinical setting and availability .
- Clinical condition of the patients with accute upper gastrointstinal bleeding after 48 hours from endoscopy [ Time Frame: 48 hours ]
- number of participants with variceal bleeding and other causes of upper gastrointestinal bleeding regarding the clinical condition after 48 hours [ Time Frame: 48 hours ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02405286
|Egypt Ain Shams center University Hospitals|